Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 pseudogene 19 (RPL7P19) is a processed pseudogene derived from the gene encoding ribosomal protein L7, a component of the 60S ribosomal subunit essential for protein synthesis[2][4]. Pseudogenes like RPL7P19 are non-functional genomic sequences that resemble protein-coding genes but typically lack the ability to produce a functional protein product[4]. There are numerous independent ribosomal protein L7 pseudogenes throughout the human genome, none of which code for the active ribosomal protein[4][2]. As a pseudogene, RPL7P19 is not a functional gene, is not categorized as a receptor, enzyme, transporter, or typical druggable target, and has no therapeutic role or established function in disease. Diseases connected to the parent RPL7 gene do not apply to this specific pseudogene[3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 19 (RPL7P19).